BioProcess Technology Consultants Overview

  • Founded
  • 1994
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1
  • Investments
  • 1

BioProcess Technology Consultants General Information

Description

Provider of chemistry, manufacturing and control services for the biopharmaceutical industry based in Woburn, Massachusetts. The company offers consulting services in the areas of manufacturing strategy and operations, quality and regulatory, process and analytical development, process economic modelling, opportunity assessment, de-risking the technical and regulatory challenges in the development and commercialization of biopharmaceutical products that improve patients' lives.

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Practice Management (Healthcare)
Parent Company
Primary Office
  • 12 Gill Street
  • Suite 5450
  • Woburn, MA 01801-1728
  • United States
+1 (781) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioProcess Technology Consultants Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioProcess Technology Consultants‘s full profile, request access.

Request a free trial

BioProcess Technology Consultants Executive Team (1)

Name Title Board Seat Contact Info
Howard Levine Ph.D Founder, President, and Chief Executive Officer
To view BioProcess Technology Consultants’s complete executive team members history, request access »

BioProcess Technology Consultants Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 0000000 000000 20-Oct-2014 000000000000000000 Consulting Services (B2B) 000000 000000 00.0
To view BioProcess Technology Consultants’s complete acquisitions history, request access »